Neutralizing Monoclonal Antibodies
Showing 1 - 25 of 9,507
Coronavirus Infections Trial in Moscow (tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab)
Active, not recruiting
- Coronavirus Infections
- tixagevimab/cilgavimab 150+150 mg
- +2 more
-
Moscow, Russian FederationMoscow City Clinical Hospital 52
Aug 7, 2023
TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use
Recruiting
- COVID-19
- casirivimab with imdevimab
- +2 more
-
Amsterdam, Noord Holland, Netherlands
- +3 more
Jan 13, 2022
COVID-19; Isolation of Neutralizing Antibodies for Therapeutics
Active, not recruiting
- SARS-CoV 2
- Blood sampling
-
Grenoble, FranceUniversityGrenobleHospital
Mar 24, 2022
Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)
Not yet recruiting
- Human Immunodeficiency Virus
- 3BNC117-LS
- +2 more
-
New York, New York
- +2 more
Jul 12, 2022
COVID-19 : Neutralizing Human Monoclonal Antibodies Against
Completed
- COVID
- Blood sample
-
Lyon, FranceHôpital de la Croix-Rousse
Jun 17, 2021
Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)
Not yet recruiting
- Acute HIV Infection
- VRC07-523LS
- +3 more
-
Birmingham, Alabama
- +35 more
Jan 30, 2023
Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
Completed
- Covid19
- Hematological Malignancy
-
Bari, Italy
- +13 more
Jun 21, 2022
COVID-19, SARS CoV 2 Infection Trial in Orléans (Collection of biological samples)
Not yet recruiting
- COVID-19
- SARS CoV 2 Infection
- Collection of biological samples
-
Orléans, FranceCentre Hospitalier Régional d'Orléans, France
Jul 21, 2022
HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)
Not yet recruiting
- HIV-1-infection
- VRC07-523LS
- +7 more
-
Pathum Wan, Bangkok, Thailand
- +1 more
Mar 8, 2023
Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)
Completed
- Clostridium Infection
- Collection of peripheral blood mononuclear cells
-
Paris, FranceMaladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
Oct 3, 2022
Hemophilia B Trial (CSL222 (AAV5-hFIXco-Padua))
Not yet recruiting
- Hemophilia B
- CSL222 (AAV5-hFIXco-Padua)
- (no location specified)
Aug 14, 2023
Broadly HIV-1 Neutralizing Antibodies in HIV-infected Mbeya,
Active, not recruiting
- HIV/AIDS
-
Mbeya, TanzaniaNIMR-Mbeya Medical Research Center (MMRC)
Aug 5, 2022
HIV Trial in South Africa (VRC01.23LS, PGT121.414.LS, PGDM1400LS)
Not yet recruiting
- HIV Infections
- VRC01.23LS
- +2 more
-
Cape Town, Western Cape, South Africa
- +7 more
Jul 24, 2023
Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)
Not yet recruiting
- Hepatitis b Virus
- HepB mAb19
- Sterile Saline
-
New York, New York
- +1 more
May 12, 2023
Japanese Encephalitis, Vaccine Preventable Disease, Vaccine Reaction Trial in Lishui, Quzhou, Wenzhou (Japanese Encephalitis
Active, not recruiting
- Japanese Encephalitis
- +2 more
- Japanese Encephalitis Vaccine (Vero Cell), Inactivated;
- No prospective interventions
-
Lishui, Zhejiang, China
- +2 more
Nov 13, 2022
Medicare Anti-Aß mAb Coverage With Evidence Development Study
Recruiting
- Mild Alzheimer's Disease
- Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
-
Baltimore, MarylandCenters for Medicare and Medicaid Services
Sep 21, 2023
Treatment of BK Virus Infection in Hematopoietic Stem Cell
Recruiting
- BK Virus Infection
-
Strasbourg, FranceService Laboratoire de Virologie - PTM - CHU de Strasbourg - Fra
Nov 8, 2022
Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment
Recruiting
- COVID-19 Convalescent Plasma Treatment
-
Strasbourg, FranceService des Maladies Infectieuses et Tropicales - CHU de Strasbo
Jun 15, 2023
SARS-COV-2/COVID-19 Neutralizing Antibodies in Blood
Completed
- SARS-CoV2 Infection
-
Starkville, Mississippi
- +4 more
Aug 8, 2022
HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)
Not yet recruiting
- HIV Infections
- Teropavimab
- +4 more
- (no location specified)
Feb 6, 2023
Acquiring Convalescent Specimens for COVID-19 Antibodies
Completed
- COVID-19
- +2 more
- Blood draw
-
New York, New YorkColumbia University Irving Medical Center/NYP
Jul 18, 2022